HewaTele: Cultivating Oxygen Access in East Africa with AfricInvest's $10.5M Infusion
Deal News | Aug 18, 2025 | AfricInvest Group
AfricInvest, through its Transform Health Fund, has announced a $10.5 million investment in HewaTele, a key provider of medical oxygen in Kenya. This capital infusion will be used to construct a large-scale liquid oxygen facility in the region, capable of delivering medical-grade oxygen at a purity of 99.6% to hospitals and clinics throughout East Africa. HewaTele's operations are crucial in addressing existing oxygen access gaps, bolstering health systems, and offering essential medical care in underserved areas. This move aligns with AfricInvest's broader mission of advancing sustainable healthcare solutions across the continent.
Sectors
- Healthcare
- Private Equity
Geography
- East Africa – The investment targets improvements in healthcare delivery systems across East Africa, impacting hospitals and clinics in the region.
- Kenya – HewaTele, the company receiving the investment, is based in Kenya, making it the focal point of the financial support.
Industry
- Healthcare – The investment is focused on strengthening healthcare infrastructure, specifically addressing medical oxygen supply issues in East Africa.
- Private Equity – AfricInvest's Transform Health Fund represents the private equity sector's involvement in healthcare advancements.
Financials
- USD 10.5 million – The amount AfricInvest invested in HewaTele through the Transform Health Fund.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| AfricInvest Group | Investor | Company | AfricInvest is a private equity firm making the investment through its Transform Health Fund. |
| HewaTele | Target Company | Company | HewaTele is a Kenyan provider of medical oxygen, the recipient of AfricInvest's $10.5 million investment. |